MPSYF MorphoSys AG

USD 71.38 0.00 0
Icon

MorphoSys AG (MPSYF) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 71.38

0.00 (0.00)%

USD 2.74B

N/A

N/A

N/A

Icon

MPSYF

MorphoSys AG (USD)
COMMON STOCK | OTC
USD 71.38
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.74B

N/A

USD 71.38

MorphoSys AG (MPSYF) Stock Forecast

N/A

Based on the MorphoSys AG stock forecast from 0 analysts, the average analyst target price for MorphoSys AG is not available over the next 12 months. MorphoSys AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of MorphoSys AG is Bearish, which is based on 2 positive signals and 9 negative signals. At the last closing, MorphoSys AG’s stock price was USD 71.38. MorphoSys AG’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +263.07% over the last year.

No recent analyst target price found for MorphoSys AG
No recent average analyst rating found for MorphoSys AG

Company Overview MorphoSys AG

MorphoSys AG, together with its subsidiaries, engages in the development and commercialization of therapeutics for patients suffering from various cancers in Europe, Asia, and the United States. The company's product pipeline includes Pelabresib that is in Phase 3 trials to treat...Read More

https://www.morphosys.com

Semmelweisstrasse 7, Planegg, Germany, 82152

524

December

USD

USA

Adjusted Closing Price for MorphoSys AG (MPSYF)

Loading...

Unadjusted Closing Price for MorphoSys AG (MPSYF)

Loading...

Share Trading Volume for MorphoSys AG Shares

Loading...

Compare Performance of MorphoSys AG Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for MPSYF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To MorphoSys AG (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S -0.31 (-0.25%) USD564.56B 46.25 4.92

ETFs Containing MPSYF

Symbol Name MPSYF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About MorphoSys AG (MPSYF) Stock

Stock Target Advisor's fundamental analysis for MorphoSys AG's stock is Bearish.

Unfortunately we do not have enough data on MPSYF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on MPSYF's stock to indicate what its average analyst target is.

MPSYF stock's Price/Earning ratio is 23.90. Our analysis grades MPSYF stock's Price / Earning ratio at F. This means that MPSYF stock's Price/Earning ratio is above 56.00000000000001% of the stocks in the Biotechnology sector in the OTC exchange. Based on this MPSYF may be a overvalued for its sector.

The last closing price of MPSYF's stock was USD 71.38.

The most recent market capitalization for MPSYF is USD 2.74B.

Unfortunately we do not have enough analyst data on MPSYF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains MorphoSys AG's stock.

As per our most recent records MorphoSys AG has 524 Employees.

MorphoSys AG's registered address is Semmelweisstrasse 7, Planegg, Germany, 82152. You can get more information about it from MorphoSys AG's website at https://www.morphosys.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...